Sandra E. Reznik

Sandra E. Reznik, MD, PhD, is Section Director, Perinatal Pathology and Associate Professor, Pathology and Obstetrics & Gynecology and Women's Health at Montefiore Einstein. Her clinical focus is on pathology specimens related to pregnancy, such as placentas and products of conception and perinatal autopsies.

After obtaining her Bachelor of Arts in biology at Harvard University in 1984, Dr. Reznik earned her Doctor of Medicine and Doctor of Philosophy in pharmacology at Mount Sinai School of Medicine in 1991. She completed her residency in anatomic pathology at Cornell University Medical Center in 1994, where she was House Officer until her final year, in which she became Chief Resident. Dr. Reznik completed an Arthur Purdy Stout Society fellowship in surgical pathology at Montefiore in 1997 before completing an additional fellowship in perinatal pathology at the same institution in 1998.

Dr. Reznik’s research program is divided into two main branches. The first is the development of novel approaches to prevent preterm birth, and the second is the investigation of how the in-utero environment affects fetal well-being. While studying at Mount Sinai under the direction of Dr. Marian Orlowski, Dr. Reznik characterized the novel neuropeptide synthesizing enzyme Endopeptidase 24.15, also referred to as thimet oligopeptidase, one of several important processing enzymes discovered by Dr. Orlowski. She has over seventy-five peer-reviewed publications, has presented her work at international conferences and has been funded by the National Institutes of Health (NIH) and pharmaceutical companies.

Dr. Reznik has won the Lumara Health Research Grant Award and St. John’s University Faculty Recognition Awards for Research for several years. She is a member of the steering committee of the Preterm Birth International Collaborative, North American Branch.

Dr. Reznik’s clinical focus is on pathology specimens related to pregnancy, such as placentas and products of conception, and perinatal autopsies.

Dr. Reznik’s research program is divided into two main branches: 1) the development of novel approaches to prevent preterm birth and 2) the investigation of how the in-utero environment affects fetal well-being. She has over 75 peer-reviewed publications, has presented her work at international conferences, and has been funded by the NIH and pharmaceutical companies.